世界のカルバペネム耐性腸内細菌科細菌（CRE）検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Carbapenem-resistant Enterobacteriaceae Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1101 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、カルバペネム耐性腸内細菌科細菌（CRE）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（修正ホッジカルバペネム耐性腸内細菌科検査、最小発育阻止濃度カルバペネム耐性腸内細菌科検査、その他種類）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・カルバペネム耐性腸内細菌科細菌（CRE）検査の市場動向 ・企業の競争状況、市場シェア ・カルバペネム耐性腸内細菌科細菌（CRE）検査の種類別市場規模（修正ホッジカルバペネム耐性腸内細菌科検査、最小発育阻止濃度カルバペネム耐性腸内細菌科検査、その他種類） ・カルバペネム耐性腸内細菌科細菌（CRE）検査の用途別市場規模（病院、クリニック、その他） ・カルバペネム耐性腸内細菌科細菌（CRE）検査の北米市場規模2016-2027（アメリカ、カナダ） ・カルバペネム耐性腸内細菌科細菌（CRE）検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・カルバペネム耐性腸内細菌科細菌（CRE）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・カルバペネム耐性腸内細菌科細菌（CRE）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・カルバペネム耐性腸内細菌科細菌（CRE）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（TBA、SolGent、ELITechGroup、ALIFAX、BioMérieux） ・結論

Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.

Market Analysis and Insights: Global Carbapenem-resistant Enterobacteriaceae Testing Market
The global Carbapenem-resistant Enterobacteriaceae Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Carbapenem-resistant Enterobacteriaceae Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Carbapenem-resistant Enterobacteriaceae Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Carbapenem-resistant Enterobacteriaceae Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Carbapenem-resistant Enterobacteriaceae Testing market.

Global Carbapenem-resistant Enterobacteriaceae Testing Scope and Market Size
Carbapenem-resistant Enterobacteriaceae Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Carbapenem-resistant Enterobacteriaceae Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
Other Types

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
TBA
SolGent
ELITechGroup
ALIFAX
BioMérieux

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
1.2.3 Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Perspective (2016-2027)
2.2 Carbapenem-resistant Enterobacteriaceae Testing Growth Trends by Regions
2.2.1 Carbapenem-resistant Enterobacteriaceae Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Carbapenem-resistant Enterobacteriaceae Testing Historic Market Share by Regions (2016-2021)
2.2.3 Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Regions (2022-2027)
2.3 Carbapenem-resistant Enterobacteriaceae Testing Industry Dynamic
2.3.1 Carbapenem-resistant Enterobacteriaceae Testing Market Trends
2.3.2 Carbapenem-resistant Enterobacteriaceae Testing Market Drivers
2.3.3 Carbapenem-resistant Enterobacteriaceae Testing Market Challenges
2.3.4 Carbapenem-resistant Enterobacteriaceae Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Revenue
3.1.1 Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Revenue (2016-2021)
3.1.2 Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Players (2016-2021)
3.2 Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Carbapenem-resistant Enterobacteriaceae Testing Revenue
3.4 Global Carbapenem-resistant Enterobacteriaceae Testing Market Concentration Ratio
3.4.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carbapenem-resistant Enterobacteriaceae Testing Revenue in 2020
3.5 Carbapenem-resistant Enterobacteriaceae Testing Key Players Head office and Area Served
3.6 Key Players Carbapenem-resistant Enterobacteriaceae Testing Product Solution and Service
3.7 Date of Enter into Carbapenem-resistant Enterobacteriaceae Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Carbapenem-resistant Enterobacteriaceae Testing Breakdown Data by Type
4.1 Global Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Type (2016-2021)
4.2 Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Type (2022-2027)

5 Carbapenem-resistant Enterobacteriaceae Testing Breakdown Data by Application
5.1 Global Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Application (2016-2021)
5.2 Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size (2016-2027)
6.2 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type
6.2.1 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021)
6.2.2 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027)
6.2.3 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2027)
6.3 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application
6.3.1 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021)
6.3.2 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027)
6.3.3 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2027)
6.4 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country
6.4.1 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021)
6.4.2 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size (2016-2027)
7.2 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type
7.2.1 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021)
7.2.2 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027)
7.2.3 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2027)
7.3 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application
7.3.1 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021)
7.3.2 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027)
7.3.3 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2027)
7.4 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country
7.4.1 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021)
7.4.2 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size (2016-2027)
8.2 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type
8.2.1 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application
8.3.1 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region
8.4.1 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size (2016-2027)
9.2 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type
9.2.1 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021)
9.2.2 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027)
9.2.3 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2027)
9.3 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application
9.3.1 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021)
9.3.2 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027)
9.3.3 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2027)
9.4 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country
9.4.1 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021)
9.4.2 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size (2016-2027)
10.2 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type
10.2.1 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application
10.3.1 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country
10.4.1 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 TBA
11.1.1 TBA Company Details
11.1.2 TBA Business Overview
11.1.3 TBA Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.1.4 TBA Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
11.1.5 TBA Recent Development
11.2 SolGent
11.2.1 SolGent Company Details
11.2.2 SolGent Business Overview
11.2.3 SolGent Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.2.4 SolGent Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
11.2.5 SolGent Recent Development
11.3 ELITechGroup
11.3.1 ELITechGroup Company Details
11.3.2 ELITechGroup Business Overview
11.3.3 ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.3.4 ELITechGroup Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
11.3.5 ELITechGroup Recent Development
11.4 ALIFAX
11.4.1 ALIFAX Company Details
11.4.2 ALIFAX Business Overview
11.4.3 ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.4.4 ALIFAX Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
11.4.5 ALIFAX Recent Development
11.5 BioMérieux
11.5.1 BioMérieux Company Details
11.5.2 BioMérieux Business Overview
11.5.3 BioMérieux Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.5.4 BioMérieux Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
11.5.5 BioMérieux Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
Table 3. Key Players of Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
Table 4. Key Players of Other Types
Table 5. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Regions (2016-2021)
Table 9. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Regions (2022-2027)
Table 11. Carbapenem-resistant Enterobacteriaceae Testing Market Trends
Table 12. Carbapenem-resistant Enterobacteriaceae Testing Market Drivers
Table 13. Carbapenem-resistant Enterobacteriaceae Testing Market Challenges
Table 14. Carbapenem-resistant Enterobacteriaceae Testing Market Restraints
Table 15. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Players (2016-2021)
Table 17. Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carbapenem-resistant Enterobacteriaceae Testing as of 2020)
Table 18. Ranking of Global Top Carbapenem-resistant Enterobacteriaceae Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Carbapenem-resistant Enterobacteriaceae Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Carbapenem-resistant Enterobacteriaceae Testing Product Solution and Service
Table 22. Date of Enter into Carbapenem-resistant Enterobacteriaceae Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. TBA Company Details
Table 63. TBA Business Overview
Table 64. TBA Carbapenem-resistant Enterobacteriaceae Testing Product
Table 65. TBA Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021) & (US$ Million)
Table 66. TBA Recent Development
Table 67. SolGent Company Details
Table 68. SolGent Business Overview
Table 69. SolGent Carbapenem-resistant Enterobacteriaceae Testing Product
Table 70. SolGent Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021) & (US$ Million)
Table 71. SolGent Recent Development
Table 72. ELITechGroup Company Details
Table 73. ELITechGroup Business Overview
Table 74. ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Product
Table 75. ELITechGroup Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021) & (US$ Million)
Table 76. ELITechGroup Recent Development
Table 77. ALIFAX Company Details
Table 78. ALIFAX Business Overview
Table 79. ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Product
Table 80. ALIFAX Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021) & (US$ Million)
Table 81. ALIFAX Recent Development
Table 82. BioMérieux Company Details
Table 83. BioMérieux Business Overview
Table 84. BioMérieux Carbapenem-resistant Enterobacteriaceae Testing Product
Table 85. BioMérieux Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021) & (US$ Million)
Table 86. BioMérieux Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type: 2020 VS 2027
Figure 2. Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing Features
Figure 3. Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing Features
Figure 4. Other Types Features
Figure 5. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Carbapenem-resistant Enterobacteriaceae Testing Report Years Considered
Figure 10. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Regions (2022-2027)
Figure 14. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Players in 2020
Figure 15. Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carbapenem-resistant Enterobacteriaceae Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Carbapenem-resistant Enterobacteriaceae Testing Revenue in 2020
Figure 17. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type (2016-2027)
Figure 21. North America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application (2016-2027)
Figure 22. North America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2016-2027)
Figure 23. United States Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type (2016-2027)
Figure 27. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application (2016-2027)
Figure 28. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2016-2027)
Figure 29. Germany Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region (2016-2027)
Figure 39. China Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type (2016-2027)
Figure 47. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application (2016-2027)
Figure 48. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2016-2027)
Figure 49. Mexico Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2016-2027)
Figure 55. Turkey Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. TBA Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
Figure 59. SolGent Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
Figure 60. ELITechGroup Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
Figure 61. ALIFAX Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
Figure 62. BioMérieux Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---